Global sales of the top 10 weight-loss drugs are forecast to exceed $27bn in 2028

Projected global annual sales for the top 10 weight loss drugs, $bn

Others

$25bn

Projection

Mounjaro

Eli Lilly

20

CagriSema

Novo Nordisk

15

Saxenda

Novo Nordisk

10

5

Wegovy

Novo Nordisk

0

2022

2024

2026

2028

Projection

Others

$25bn

Mounjaro

Eli Lilly

20

CagriSema

Novo Nordisk

15

Saxenda

Novo Nordisk

10

5

Wegovy

Novo Nordisk

0

2022

2023

2024

2025

2026

2027

2028

Guardian graphic. Source: Evaluate Ltd. Note: several treatments are still in development and have not yet entered the market. Others include Haleon's Alli, Amgen's AMG 133, Pfizer's Danuglipron, Rhythm Pharmaceuticals Imcivree and Perrigo's XLS-Medical